Today's Change
+0.85%
AI Sentiment
60%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with bullish sentiment across 17 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $CINGW | Cingulate Inc - Warrants (03/12/2026) | -10.38% |
| $TMCWW | TMC the metals company Inc - Warrants (09/09/2026) | +60.68% |
| $ENGNW | enGene Holdings Inc - Warrants (31/10/2028) | +11.50% |
| $SDSTW | Stardust Power Inc - Warrants (21/06/2029) | -2.69% |
| $SCLXW | Scilex Holding Company - Warrants (10/11/2027) | -6.43% |
| $SBFMW | Sunshine Biopharma Inc - Warrants (15/02/2027) | +0.00% |
| $NAMSW | NewAmsterdam Pharma Company NV - Warrants (15/11/2027) | +21.31% |
| $DRMAW | Dermata Therapeutics Inc - Warrants (13/08/2026) | -8.87% |
| $ERNAW | Ernexa Therapeutics Inc Warrants | +63.87% |
| $JSPRW | Jasper Therapeutics Inc - Warrants (24/09/2026) | -15.64% |
| $HUMAW | Humacyte Inc - Warrants (27/08/2026) | +5.13% |
| $CDIOW | Cardio Diagnostics Holdings Inc - Warrants (01/12/2026) | -11.72% |
| $BIVIW | BioVie Inc Warrant | +9.38% |
| $BCTXL | BriaCell Therapeutics Corp Warrants | +7.53% |
| $NBY | NovaBay Pharmaceuticals, Inc. | +0.00% |
Materials News
805 articles
Benzinga45d ago
U.S. GOLD CORP. TO PARTICIPATE IN THE LYTHAM PARTNERS 2026 INDUSTRIALS & BASIC MATERIALS INVESTOR SUMMIT ON APRIL 1, 2026
GlobeNewswire Inc.45d ago
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
GlobeNewswire Inc.45d ago
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.45d ago
Gartner, Inc. Securities Fraud Class Action Result of Reduced Guidance Disclosure and 48% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.45d ago
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc.45d ago
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc.45d ago
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Market Sentiment
Bullish
60% Sentiment Score
Sector Stats
Total Stocks198
News Today17
Avg Volume1.3M
AI SentimentBullish